31439883|t|BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation.
31439883|a|HIV-1 Tat is essential for HIV-1 replication and plays an important role in latent HIV-1 infection, HIV-1 associated neurological complication, and other HIV-1 comorbidities. Secreted from HIV-1 infected or transfected cells, Tat can be up-taken into cells by receptor-mediated endocytosis and internalized into endolysosomes. To reach nucleus where it can facilitate HIV-1 viral replication, exogenous Tat has to escape the degradation by endolysosomes. Because of findings that endolysosome de-acidification with, for example, the weak-base anti-malarial drug chloroquine prevents exogenous Tat degradation and enhances the amount of Tat available to activate HIV-1 LTR, we hypothesize that acidifying endolysosomes may enhance Tat degradation in endolysosomes and restrict LTR transactivation. Here, we determined the involvement of endolysosome-resident transient receptor potential mucolipin 1 channel (TRPML1) and the big conductance Ca2+-activated potassium (BK) channel in regulating endolysosome pH, as well as Tat-mediated HIV-1 LTR transactivation in U87MG cells stably integrated with HIV-1 LTR luciferase reporter. Activating TRPML1 channels with ML-SA1 acidified endolysosomes and restricted Tat-mediated HIV-1 LTR transactivation. These effects of ML-SA1 appeared to be mediated through activation of BK channels, because the effects of ML-SA1 on Tat-mediated HIV-1 LTR transactivation were blocked using pharmacological inhibitors or shRNA knock-down of BK channels. On the other hand, activating TRPML1 and BK channels enhanced cellular degradation of exogenous Tat. These results suggest that acidifying endolysosomes by activating TRPML1 or BK channels may provide therapeutic benefit against latent HIV-1 infection, HIV-1 associated neurocognitive disorders, and other HIV-1 comorbidities.
31439883	0	11	BK channels	Gene	
31439883	35	38	Tat	Gene	6898
31439883	48	53	HIV-1	Species	11676
31439883	75	80	HIV-1	Species	11676
31439883	81	84	Tat	Gene	6898
31439883	102	107	HIV-1	Species	11676
31439883	158	173	HIV-1 infection	Disease	MESH:D015658
31439883	175	180	HIV-1	Species	11676
31439883	192	217	neurological complication	Disease	MESH:D002493
31439883	229	234	HIV-1	Species	11676
31439883	264	269	HIV-1	Species	11676
31439883	301	304	Tat	Gene	6898
31439883	443	448	HIV-1	Species	11676
31439883	478	481	Tat	Gene	6898
31439883	637	648	chloroquine	Chemical	MESH:D002738
31439883	668	671	Tat	Gene	6898
31439883	711	714	Tat	Gene	6898
31439883	737	742	HIV-1	Species	11676
31439883	805	808	Tat	Gene	6898
31439883	933	981	transient receptor potential mucolipin 1 channel	Gene	
31439883	983	989	TRPML1	Gene	57192
31439883	999	1052	big conductance Ca2+-activated potassium (BK) channel	Gene	
31439883	1095	1098	Tat	Gene	6898
31439883	1108	1113	HIV-1	Species	11676
31439883	1137	1142	U87MG	CellLine	CVCL:0022
31439883	1172	1177	HIV-1	Species	11676
31439883	1214	1220	TRPML1	Gene	57192
31439883	1235	1241	ML-SA1	Chemical	-
31439883	1281	1284	Tat	Gene	6898
31439883	1294	1299	HIV-1	Species	11676
31439883	1338	1344	ML-SA1	Chemical	-
31439883	1427	1433	ML-SA1	Chemical	-
31439883	1437	1440	Tat	Gene	6898
31439883	1450	1455	HIV-1	Species	11676
31439883	1588	1594	TRPML1	Gene	57192
31439883	1599	1610	BK channels	Gene	
31439883	1654	1657	Tat	Gene	6898
31439883	1725	1731	TRPML1	Gene	57192
31439883	1735	1746	BK channels	Gene	
31439883	1794	1809	HIV-1 infection	Disease	MESH:D015658
31439883	1811	1816	HIV-1	Species	11676
31439883	1828	1852	neurocognitive disorders	Disease	MESH:D019965
31439883	1864	1869	HIV-1	Species	11676
31439883	Negative_Correlation	MESH:D002738	6898
31439883	Association	MESH:D019965	57192
31439883	Association	MESH:D015658	57192
31439883	Association	MESH:D015658	6898
31439883	Association	57192	6898
31439883	Association	MESH:D002493	6898

